Structure-activity relationships of isoeugenol-based chlorophenylpiperazine derivatives on serotonergic/adrenergic receptor, platelet aggregation, and lipid peroxidation-Reference-Cited by-同舟云学术

Structure-activity relationships of isoeugenol-based chlorophenylpiperazine derivatives on serotonergic/adrenergic receptor, platelet aggregation, and lipid peroxidation

Published:2010-06-30 Issue:5 Volume:71 Page:285-293
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Shen Kuo-Ping,Chang Wen-Tsan,Lin Hui-Li,Chu Li-Wen,Chen Ing-Jun,Wu Bin-Nan

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.20373/fullpdf

Reference23 articles.

1. Alpha-2A and alpha-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype;Bylund;J Pharmacol Exp Ther,1988

2. Primary structure of the human platelet serotonin 5-HT2A receptor: identity with frontal cortex serotonin 5-HT2A receptor;Cook;J Neurochem,1994

3. Alpha 2-adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs;Garcia-Sevilla;Eur J Pharmacol,1981

4. A new aspect of view in synthesizing new type beta-adrenoceptor blockers with ancillary antioxidant activities;Huang;Bioorg Med Chem,2001

5. Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries;Ishida;Circulation,2001

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. (Hetero)Aryloxyaminopropanols with N-Phenylpiperazine Structural Fragment – Review of Cardiovascular Activity;Mini-Reviews in Medicinal Chemistry;2020-11-18

2. Eugenosedin-A ameliorates hyperlipidemia-induced vascular endothelial dysfunction via inhibition of α1-adrenoceptor/5-HT activity and NADPH oxidase expression;The Kaohsiung Journal of Medical Sciences;2014-03

3. Eugenosedin-A prevents high-fat diet increased adhesion molecules through inhibition of MAPK- and p65-mediated NF-κB pathway in rat model;Journal of Pharmacy and Pharmacology;2012-10-12